Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
Surg Endosc ; 32(12): 4900-4911, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-29869083

RESUMEN

BACKGROUND: Small bowel obstruction (SBO) continues to be a common indication for acute care surgery. While open procedures are still widely used for treatment, laparoscopic procedures may have important advantages in certain patient populations. We aim to analyze differences in outcomes between the two for treatment of bowel obstruction. METHODS: The American College of Surgeons National Surgical Quality Improvement Program was used to find patients that underwent emergent or non-elective surgery for SBO. Propensity matching was used to create comparable groups. Logistic regression was used to assess differences in the primary outcome of interest, return to operating room, and morbidity and mortality outcomes. Logistic regression was also used to assess the contribution of various preoperative demographic and comorbidity characteristics to 30-day mortality. RESULTS: A total of 24,028 patients underwent surgery for SBO from 2005 to 2011. Of those, 3391 were laparoscopic. Propensity matching resulted in 6782 matched patients. Laparoscopic cases had significantly decreased odds of experiencing any morbidity and wound complications compared to open cases in bowel-resection and adhesiolysis-only cases. There was no significant difference found for odds of returning to operating room. Laparoscopic cases resulted in significantly shorter hospital stays than open cases (7.18 vs.10.84 days, p < 0.0001). Increasing age, American Society of Anesthesiologists class greater than three, and the presence of respiratory comorbidities resulted in increased odds of mortality. Underweight body mass index (BMI) (< 18.5) increased odds of mortality while greater than normal BMI (> 25) decreased odds of mortality. CONCLUSIONS: Analysis of emergent SBO cases between 2005 and 2015 demonstrates that laparoscopy is not utilized as often as open approaches in surgical treatment. Laparoscopic surgery resulted in reduced postoperative morbidity and significantly shorter hospital stays compared to open intervention and was not associated with significant differences in odds of reoperation compared to open surgery.


Asunto(s)
Procedimientos Quirúrgicos del Sistema Digestivo/métodos , Urgencias Médicas , Predicción , Obstrucción Intestinal/cirugía , Intestino Delgado/cirugía , Laparoscopía/métodos , Complicaciones Posoperatorias/epidemiología , Adulto , Femenino , Estudios de Seguimiento , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Morbilidad/tendencias , Estudios Retrospectivos , Tasa de Supervivencia/tendencias , Estados Unidos/epidemiología
3.
J Invest Dermatol ; 138(6): 1391-1399, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29288650

RESUMEN

Cooling or the application of mentholated liniments to the skin has been used to treat itch for centuries, yet remarkably little is known about how counter-stimuli such as these induce itch relief. Indeed, there is no clear consensus in the scientific literature as to whether or not cooling does in fact block the transduction of itch signals or if it is simply a placebo effect. This gap in our understanding led us to hypothesize that cooling is antipruritic and, like cooling analgesia, requires function of the cold-gated ion channel TRPM8, a receptor for menthol expressed on peripheral afferent nerve endings. Using a combination of pharmacologic, genetic, and mouse behavioral assays, we find that cooling inhibits both histaminergic and non-histaminergic itch pathways, and that inhibition of itch by cooling requires TRPM8 channels or intact and functional TRPM8-expressing afferent neurons. The cold mimetic menthol is also effective in ameliorating itch in a TRPM8-dependent manner. Moreover, we find that chronic itch can be ameliorated by cooling, demonstrating that this counter-stimulus activates a specific neural circuit that leads to broad itch relief and a potential cellular mechanism for treatment of chronic itch.


Asunto(s)
Antipruriginosos/farmacología , Crioterapia , Prurito/terapia , Células Receptoras Sensoriales/metabolismo , Canales Catiónicos TRPM/metabolismo , Animales , Antipruriginosos/uso terapéutico , Conducta Animal/efectos de los fármacos , Capsaicina/toxicidad , Cloroquina/toxicidad , Enfermedad Crónica/terapia , Modelos Animales de Enfermedad , Histamina/toxicidad , Humanos , Mentol/farmacología , Mentol/uso terapéutico , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Prurito/inducido químicamente , Prurito/patología , Células Receptoras Sensoriales/efectos de los fármacos , Piel/efectos de los fármacos , Piel/inervación , Piel/metabolismo , Piel/patología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA